Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study.

Delphi technique diagnosis post-thrombotic syndrome thoracic outlet syndrome upper extremity deep vein thrombosis

Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
08 2022
Historique:
revised: 19 04 2022
received: 27 01 2022
accepted: 12 05 2022
pubmed: 25 5 2022
medline: 23 7 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Primary deep vein thrombosis of the upper extremity (UEDVT) is a rare condition but up to 60% of patients may develop post-thrombotic syndrome in the upper extremity (UE-PTS) with significant morbidity and decreased quality of life. However, there is no universally accepted method to diagnose and classify UE-PTS, hampering scientific research on UEDVT treatment. Through this international Delphi consensus study we aimed to determine what a clinical score for diagnosing UE-PTS should entail. An online focus group survey among 20 patients treated for UEDVT was performed to provide clinical parameters before the start of a four round electronic Delphi consensus study among 25 international experts. The CREDES recommendations on Conducting and Reporting Delphi Studies were applied. Open text questions, multiple selection questions, and 9-point Likert scales were used. Consensus was set at 70% agreement. After four rounds, agreement was reached on a composite score of five symptoms and three clinical signs, combined with a functional disability score. The signs and symptom will each be scored on a severity scale of 0-3 and the total score expressed as an ordinal variable; no/mild/moderate/or severe PTS. The functional disability portion measures the impact of the signs and symptoms on the functionality of the patient's arm. Consensus was reached on a composite score of signs and symptoms of UE-PTS combined with a functional disability score. Clinical validation of the UE-PTS score in a large patient cohort is mandatory to facilitate application in future research.

Identifiants

pubmed: 35608971
doi: 10.1111/jth.15767
pmc: PMC9545993
pii: S1538-7836(22)02079-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1880-1886

Informations de copyright

© 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.

Références

Palliat Med. 2017 Sep;31(8):684-706
pubmed: 28190381
Am J Ind Med. 1996 Jun;29(6):602-8
pubmed: 8773720
J Vasc Surg Venous Lymphat Disord. 2021 May;9(3):801-810.e5
pubmed: 33540134
J Bone Joint Surg Am. 2005 May;87(5):1038-46
pubmed: 15866967
BMJ. 1995 Aug 5;311(7001):376-80
pubmed: 7640549
Orthopedics. 1981 Sep 1;4(9):1025-9
pubmed: 24822735
Eur J Vasc Surg. 1988 Jun;2(3):161-5
pubmed: 3410064
Ann Vasc Surg. 2017 Apr;40:303-326
pubmed: 27666803
Ann Vasc Surg. 2021 Jan;70:263-272
pubmed: 32771464
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1025-1030
pubmed: 32205129
Eur J Vasc Endovasc Surg. 2021 Jan;61(1):9-82
pubmed: 33334670
Ann Thorac Surg. 2009 Feb;87(2):416-22
pubmed: 19161749
Thromb Res. 2010 Jun;125(6):e335-8
pubmed: 20406709
J Vasc Surg. 2013 Jan;57(1):254-61
pubmed: 23182156
Thromb Res. 2020 Jun;190:45-51
pubmed: 32298840
Acad Med. 2016 May;91(5):663-8
pubmed: 26796090
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1159-1167.e2
pubmed: 33429091
Thromb Haemost. 2005 Mar;93(3):499-502
pubmed: 15735801
J Thromb Haemost. 2009 May;7(5):884-8
pubmed: 19320818
Thromb Res. 2019 Feb;174:34-39
pubmed: 30553163
Thromb Res. 2019 Jun;178:59-62
pubmed: 30980999
Thromb Res. 2006;117(6):609-14
pubmed: 16002126
J Thromb Haemost. 2022 Aug;20(8):1880-1886
pubmed: 35608971
Eur J Vasc Endovasc Surg. 2017 May;53(5):744-751
pubmed: 28342731
Br J Surg. 2013 Oct;100(11):1459-64
pubmed: 24037565

Auteurs

Robert J C M F de Kleijn (RJCMF)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Ludo Schropp (L)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Eline S van Hattum (ES)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Çagdas Ünlu (Ç)

Department of Vascular Surgery, Noordwest-Ziekenhuisgroep, Alkmaar, The Netherlands.

Saskia Middeldorp (S)

Department of Internal Medicine & Radboud Institute of Health Sciences (RIHS), Radboud University Medical Center, Nijmegen, The Netherlands.

Mathilde Nijkeuter (M)

Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Jan Westerink (J)

Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Bart-Jeroen Petri (BJ)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Gert J de Borst (GJ)

Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH